{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:25:55Z","timestamp":1788218755596,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007785","name":"Jinan Science and Technology Bureau","doi-asserted-by":"publisher","award":["202134064"],"award-info":[{"award-number":["202134064"]}],"id":[{"id":"10.13039\/100007785","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taishan Scholars Program of Shandong Province","award":["tsqnz202408368"],"award-info":[{"award-number":["tsqnz202408368"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002832"],"award-info":[{"award-number":["82002832"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2024MH190"],"award-info":[{"award-number":["ZR2024MH190"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"International diabetes Exchange and Practice Special fund of China, the International Medical Exchange Foundation","award":["Z-2017-26-2202-4"],"award-info":[{"award-number":["Z-2017-26-2202-4"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02172-7","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T10:05:27Z","timestamp":1769162727000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Calcitonin-negative medullary thyroid carcinoma combined with multifocal papillary thyroid carcinoma: a case report and literature review"],"prefix":"10.1186","volume":"26","author":[{"given":"Wenjing","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Ci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"2172_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020.","journal-title":"Thyroid"},{"key":"2172_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4158\/ep.7.3.202","volume":"7","author":"RH Cobin","year":"2001","unstructured":"Cobin RH, Gharib H, Bergman DA, et al. AACE\/AAES MEDICAL\/SURGICAL guidelines for clinical practice: management of thyroid carcinoma. Endocr Pract. 2001;7:202\u201320. https:\/\/doi.org\/10.4158\/ep.7.3.202.","journal-title":"Endocr Pract"},{"key":"2172_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s13304-012-0152-5","volume":"65","author":"D Verdi","year":"2012","unstructured":"Verdi D, Pennelli G, Galuppini F, Pelizzo MR, Toniato A. Synchronous medullary, papillary and follicular carcinomas in the same thyroid: case report and review of literature. Updates Surg. 2012;65:329\u201332. https:\/\/doi.org\/10.1007\/s13304-012-0152-5.","journal-title":"Updates Surg"},{"key":"2172_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3803\/enm.2015.30.2.221","volume":"30","author":"GY Kim","year":"2015","unstructured":"Kim GY, Park CY, Cho CH, Park JS, Jung ED, Jeon EJ. A calcitonin-negative neuroendocrine tumor derived from follicular lesions of the thyroid. Endocrinol Metab. 2015;30:221\u20135. https:\/\/doi.org\/10.3803\/enm.2015.30.2.221.","journal-title":"Endocrinol Metab"},{"key":"2172_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1177\/1066896916670989","volume":"25","author":"M Parmer","year":"2017","unstructured":"Parmer M, Milan S, Torabi A. Calcitonin-negative neuroendocrine tumor of the thyroid. Int J Surg Pathol. 2017;25:191\u20134. https:\/\/doi.org\/10.1177\/1066896916670989.","journal-title":"Int J Surg Pathol"},{"key":"2172_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1089\/thy.2010.0299","volume":"21","author":"VS Chernyavsky","year":"2011","unstructured":"Chernyavsky VS, Farghani S, Davidov T, Ma L, Barnard N, Amorosa LF, Trooskin SZ. Calcitonin-negative neuroendocrine tumor of the thyroid: a distinct clinical entity. Thyroid. 2011;21:193\u20136. https:\/\/doi.org\/10.1089\/thy.2010.0299.","journal-title":"Thyroid"},{"key":"2172_CR7","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3978\/j.issn.2227-684X.2015.01.02","volume":"4","author":"O Ismi","year":"2015","unstructured":"Ismi O, Arpaci RB, Berkesoglu M, Dag A, Sezer E, Bal KK, Vayisoglu Y. Calcitonin-negative neuroendocrine tumor of thyroid gland mimicking anaplastic carcinoma: an unusual entity. Gland Surg. 2015;4:344\u20139. https:\/\/doi.org\/10.3978\/j.issn.2227-684X.2015.01.02.","journal-title":"Gland Surg"},{"key":"2172_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.12998\/wjcc.v8.i1.179","volume":"8","author":"HJ Cai","year":"2020","unstructured":"Cai HJ, Wang H, Cao N, Huang B, Kong FL, Lu LE, Huang YY, Wang W. Calcitonin-negative neuroendocrine tumor of the thyroid with metastasis to liver-rare presentation of an unusual tumor: a case report and review of literature. World J Clin Cases. 2020;8:179\u201387. https:\/\/doi.org\/10.12998\/wjcc.v8.i1.179.","journal-title":"World J Clin Cases"},{"key":"2172_CR9","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1007\/s00432-016-2169-5","volume":"142","author":"MT Sam\u00e0","year":"2016","unstructured":"Sam\u00e0 MT, Rossetto Giaccherino R, Gallo M, Felicetti F, Maletta F, Bonelli N, Piovesan A, Palestini N, Ghigo E, Arvat E. Clinical challenges with calcitonin-negative medullary thyroid carcinoma. J Cancer Res Clin Oncol. 2016;142:2023\u20139. https:\/\/doi.org\/10.1007\/s00432-016-2169-5.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2172_CR10","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1056\/nejm198902163200707","volume":"320","author":"RE Sobol","year":"1989","unstructured":"Sobol RE, Memoli V, Deftos LJ. Hormone-negative, chromogranin a-positive endocrine tumors. N Engl J Med. 1989;320:444\u20137. https:\/\/doi.org\/10.1056\/nejm198902163200707.","journal-title":"N Engl J Med"},{"key":"2172_CR11","doi-asserted-by":"publisher","first-page":"e236865","DOI":"10.1136\/bcr-2020-236865","volume":"13","author":"G Montgomery","year":"2020","unstructured":"Montgomery G, Collins L, Coghlin C, Ullah R. Calcitonin negative medullary thyroid cancer in ectopic thyroid tissue: a rare diagnosis in an unusual location. BMJ Case Rep. 2020;13:e236865. https:\/\/doi.org\/10.1136\/bcr-2020-236865.","journal-title":"BMJ Case Rep"},{"key":"2172_CR12","doi-asserted-by":"publisher","first-page":"747704","DOI":"10.3389\/fendo.2021.747704","volume":"12","author":"SJ Kim","year":"2021","unstructured":"Kim SJ, Yun HJ, Shin S-J, Lee YS, Chang HS. Serum calcitonin-negative medullary thyroid carcinoma: a case series of 19 patients in a single center. Front Endocrinol. 2021;12:747704. https:\/\/doi.org\/10.3389\/fendo.2021.747704.","journal-title":"Front Endocrinol"},{"key":"2172_CR13","doi-asserted-by":"publisher","first-page":"e32088","DOI":"10.7759\/cureus.32088","volume":"14","author":"W Rafaey","year":"2022","unstructured":"Rafaey W, Munir Alvi A, Siddiqi AI, Shafiq W, Irfan H. Case report: a challenging clinical problem of calcitonin-negative medullary thyroid cancer diagnosis and surveillance. Cureus. 2022;14:e32088. https:\/\/doi.org\/10.7759\/cureus.32088.","journal-title":"Cureus"},{"key":"2172_CR14","doi-asserted-by":"publisher","first-page":"e40290","DOI":"10.7759\/cureus.40290","volume":"15","author":"J Ukrani","year":"2023","unstructured":"Ukrani J, Barnes M, Ashraf A, Haggerty G, Dacosta N. Uncovering the uncommon: an 81-year-old woman with elevated carcinoembryonic antigen (CEA) but normal calcitonin levels diagnosed with medullary thyroid carcinoma. Cureus. 2023;15:e40290. https:\/\/doi.org\/10.7759\/cureus.40290.","journal-title":"Cureus"},{"key":"2172_CR15","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1308\/rcsann.2019.0153","volume":"102","author":"DC Murphy","year":"2020","unstructured":"Murphy DC, Johnson SJ, Aspinall S. Calcitonin-negative medullary thyroid carcinoma: the \u2018triple-negative\u2019 phenotype. Ann R Coll Surg Engl. 2020;102:e63\u20136. https:\/\/doi.org\/10.1308\/rcsann.2019.0153.","journal-title":"Ann R Coll Surg Engl"},{"key":"2172_CR16","doi-asserted-by":"publisher","first-page":"1025629","DOI":"10.3389\/fendo.2022.1025629","volume":"13","author":"W Yue","year":"2022","unstructured":"Yue W, Zhang Y. Oncologic outcomes of calcitonin-negative medullary thyroid carcinoma. Front Endocrinol. 2022;13:1025629. https:\/\/doi.org\/10.3389\/fendo.2022.1025629.","journal-title":"Front Endocrinol"},{"key":"2172_CR17","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1089\/thy.2007.0231","volume":"18","author":"JM Dora","year":"2008","unstructured":"Dora JM, Canalli MHBDS, Capp C, Pu\u00f1ales MK, Vieira JGH, Maia AL. Normal perioperative serum calcitonin levels in patients with advanced medullary thyroid carcinoma: case report and review of the literature. Thyroid. 2008;18:895\u20139. https:\/\/doi.org\/10.1089\/thy.2007.0231.","journal-title":"Thyroid"},{"key":"2172_CR18","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1089\/thy.2000.10.919","volume":"10","author":"A Redding","year":"2000","unstructured":"Redding A, Levine S, Fowler M. Normal preoperative calcitonin levels do not always exclude medullary thyroid carcinoma in patients with large palpable thyroid masses. Thyroid. 2000;10:919\u201322. https:\/\/doi.org\/10.1089\/thy.2000.10.919.","journal-title":"Thyroid"},{"key":"2172_CR19","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1089\/thy.2012.0236","volume":"23","author":"K Frank-Raue","year":"2013","unstructured":"Frank-Raue K, Machens A, Leidig-Bruckner G, Rondot S, Haag C, Schulze E, Lorenz A, Kreissl MC, Dralle H, Raue F, Schmid KW. Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma. Thyroid. 2013;23:294\u2013300. https:\/\/doi.org\/10.1089\/thy.2012.0236.","journal-title":"Thyroid"},{"key":"2172_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1210\/jc.2014-3095","volume":"100","author":"EF Brutsaert","year":"2015","unstructured":"Brutsaert EF, Gersten AJ, Tassler AB, Surks MI. Medullary thyroid cancer with undetectable serum calcitonin. J Clin Endocrinol Metab. 2015;100:337\u201341. https:\/\/doi.org\/10.1210\/jc.2014-3095.","journal-title":"J Clin Endocrinol Metab"},{"key":"2172_CR21","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/1097-0142(19830915)52:6<1053::aid-cncr2820520621>3.0.co;2-q","volume":"52","author":"O Ljungberg","year":"1983","unstructured":"Ljungberg O, Ericsson UB, Bondeson L, Thorell J. A compound follicular-parafollicular cell carcinoma of the thyroid: a new tumor entity? Cancer. 1983;52:1053\u201361. https:\/\/doi.org\/10.1002\/1097-0142(19830915)52:6%3C1053::aid-cncr2820520621%3E3.0.co;2-q.","journal-title":"Cancer"},{"key":"2172_CR22","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/s0002-9440(10)65465-x","volume":"155","author":"M Volante","year":"1999","unstructured":"Volante M, Papotti M, Roth J, Saremaslani P, Speel EJM, Lloyd RV, Carney JA, Heitz PU, Bussolati G, Komminoth P. Mixed medullary-follicular thyroid carcinoma. Molecular evidence for a dual origin of tumor components. Am J Pathol. 1999;155:1499\u2013509. https:\/\/doi.org\/10.1016\/s0002-9440(10)65465-x.","journal-title":"Am J Pathol"},{"key":"2172_CR23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1440-1827.2006.01995.x","volume":"56","author":"P Zhang","year":"2006","unstructured":"Zhang P, Zuo H, Ozaki T, Nakagomi N, Kakudo K. Cancer stem cell hypothesis in thyroid cancer. Pathol Int. 2006;56:485\u20139. https:\/\/doi.org\/10.1111\/j.1440-1827.2006.01995.x.","journal-title":"Pathol Int"},{"key":"2172_CR24","doi-asserted-by":"publisher","first-page":"1153248","DOI":"10.3389\/fendo.2023.1153248","volume":"14","author":"D Zhang","year":"2023","unstructured":"Zhang D, Yang M, Zhang X, Wang C, Li K, Wang H, Chi H, Sui C, Dionigi G, Sun H. Thirty synchronous medullary and papillary thyroid carcinomas. Front Endocrinol. 2023;14:1153248. https:\/\/doi.org\/10.3389\/fendo.2023.1153248.","journal-title":"Front Endocrinol"},{"key":"2172_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1677\/erc.1.00901","volume":"12","author":"S Rossi","year":"2005","unstructured":"Rossi S, Fugazzola L, Pasquale LD, Braidotti P, Cirello V, Beck-Peccoz P, Bosari S, Bastagli A. Medullary and papillary carcinoma of the thyroid gland occurring as a collision tumour: report of three cases with molecular analysis and review of the literature. Endocr Relat Cancer. 2005;12:281\u20139. https:\/\/doi.org\/10.1677\/erc.1.00901.","journal-title":"Endocr Relat Cancer"},{"key":"2172_CR26","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s12022-012-9217-8","volume":"23","author":"P Zoroquiain","year":"2012","unstructured":"Zoroquiain P, Torres J, Go\u00f1i I, Fern\u00e1ndez L, Solar A. True mixed medullary papillary carcinoma of the thyroid: a case report with low blood calcitonin levels. Endocr Pathol. 2012;23:168\u201371. https:\/\/doi.org\/10.1007\/s12022-012-9217-8.","journal-title":"Endocr Pathol"},{"key":"2172_CR27","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/dc.23924","volume":"46","author":"Y Liu","year":"2018","unstructured":"Liu Y, Yuan L, Yang D, Jin Y. Serum calcitonin negative mixed medullary-follicular carcinoma initially diagnosed as medullary thyroid carcinoma by fine-needle aspiration cytology: a case report and review of the literatures. Diagn Cytopathol. 2018;46:690\u20133. https:\/\/doi.org\/10.1002\/dc.23924.","journal-title":"Diagn Cytopathol"},{"key":"2172_CR28","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s12105-021-01323-7","volume":"15","author":"A Thomas","year":"2021","unstructured":"Thomas A, Mittal N, Rane SU, Bal M, Patil A, Ankathi SK, Vaish R. Papillary and medullary thyroid carcinomas presenting as collision tumors: a case series of 21 cases at a tertiary care cancer center. Head Neck Pathol. 2021;15:1137\u201346. https:\/\/doi.org\/10.1007\/s12105-021-01323-7.","journal-title":"Head Neck Pathol"},{"key":"2172_CR29","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1089\/thy.2004.14.946","volume":"14","author":"RP Biscolla","year":"2004","unstructured":"Biscolla RP, Ugolini C, Sculli M, et al. Medullary and papillary tumors are frequently associated in the same thyroid gland without evidence of reciprocal influence in their biologic behavior. Thyroid. 2004;14:946\u201352. https:\/\/doi.org\/10.1089\/thy.2004.14.946.","journal-title":"Thyroid"},{"key":"2172_CR30","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.eprac.2020.10.011","volume":"27","author":"G Barbesino","year":"2021","unstructured":"Barbesino G, Algeciras-Schimnich A, Bornhorst JA. False positives in thyroglobulin determinations due to the presence of heterophile antibodies: an underrecognized and consequential clinical problem. Endocr Pract. 2021;27:396\u2013400. https:\/\/doi.org\/10.1016\/j.eprac.2020.10.011.","journal-title":"Endocr Pract"},{"key":"2172_CR31","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.beem.2013.05.011","volume":"27","author":"N Bolstad","year":"2013","unstructured":"Bolstad N, Warren DJ, Nustad K. Heterophilic antibody interference in immunometric assays. Best Pract Res Clin Endocrinol Metab. 2013;27:647\u201361. https:\/\/doi.org\/10.1016\/j.beem.2013.05.011.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2172_CR32","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1515\/cclm.2009.230","volume":"47","author":"L Giovanella","year":"2009","unstructured":"Giovanella L, Keller F, Ceriani L, Tozzoli R. Heterophile antibodies May falsely increase or decrease thyroglobulin measurement in patients with differentiated thyroid carcinoma. Clin Chem Lab Med. 2009;47:952\u20134. https:\/\/doi.org\/10.1515\/cclm.2009.230.","journal-title":"Clin Chem Lab Med"},{"key":"2172_CR33","doi-asserted-by":"publisher","first-page":"bvac169","DOI":"10.1210\/jendso\/bvac169","volume":"7","author":"G Barbesino","year":"2022","unstructured":"Barbesino G, Algeciras-Schimnich A, Bornhorst J. Thyroglobulin assay interferences: clinical usefulness of mass-spectrometry methods. J Endocr Soc. 2022;7:bvac169. https:\/\/doi.org\/10.1210\/jendso\/bvac169.","journal-title":"J Endocr Soc"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02172-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02172-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02172-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T17:06:40Z","timestamp":1771434400000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02172-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2172"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02172-7","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"27 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the First Affiliated Hospital of Shandong First Medical University (IRB ID: S841). It was conducted in accordance with the ethical standards established in the 1964 Declaration of Helsinki and its subsequent amendments. The conducted of this study have obtained written informed consent from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The publication of this study have obtained written informed consent from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}